Yassir Mahgoub, MD

  • 9Articles
  • 58.3KReads
  • 2016–2021Active
  • 14Collaborators
  • 23Citations

About

Yassir Mahgoub, MD is affiliated with Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, Pennsylvania. Yassir Mahgoub has authored or co-authored 9 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2016 and 2021. Their work focuses on Neurology, Catatonia, Addiction, Bipolar Disorder, and Gastroenterology.

Publications

PCC
Case Report

Prophylactic Antidepressants, Multiple Sclerosis, and Interferon-β

September 30, 2021

The relationship between INF-β and depression and suicidality has not been strongly established. Here, read about a woman with multiple sclerosis with new-onset depression who was taking fluoxetine in...
, , , et al
PCC
Case Report

Potato Chips and Potentially Toxic Lithium Level

August 19, 2021

Here, read about a patient with bipolar disorder who was maintained on lithium, but changes in the salt content of her food when she was in the hospital resulted...
,
PCC
Case Report

When Nothing Stops Catatonia Except ECT and Clozapine

July 22, 2021

Here, the authors present a case of catatonia that failed treatment with several antipsychotics, resulting in the development of neuroleptic malignant syndrome and rhabdomyolysis. Read on to find out...
, ,
PCC
Case Report

Coprophagia as an Unusual Presentation of Catatonia

May 13, 2021

Here, read about a patient who presented with repetitive odd behavior, eating of feces, and thought perseveration that did not respond to adequate doses of 3 antipsychotics but responded...
,
PCC
Case Report

Partially Treated Catatonia and Neuroleptic Malignant Syndrome

October 8, 2020

Neuroleptic malignant syndrome (NMS) is a life-threatening condition associated with use of psychotropic medications. This report presents a case of incipient NMS in a patient who developed catatonia during...
, ,
PCC
Case Report

Green Tea Extract, Ziprasidone, and Psychosis

January 23, 2020

Food influences ziprasidone's bioavailability, and ingredients in green tea extract can affect intestinal absorption and liver metabolism. Read about a man with schizophrenia stable on ziprasidone who became psychotic...
, ,
PCC
Case Report

Schizoaffective Exacerbation in a Roux-en-Y Gastric Bypass Patient on Clozapine

December 19, 2019

Could Roux-en-Y gastric bypass surgery affect a patient's clozapine levels? Read this case report to find out more.
,
PCC
Letter to the Editor

Caffeine-Induced Psychosis in a Bodybuilder

June 21, 2018

Caffeine is the world's most-consumed psychoactive substance. It is also considered a performance-enhancing substance by athletes and bodybuilders. Here, read about caffeine's psychogenic effect on a bodybuilder who also...
,
PCC
Letter to the Editor

Covert Dyskinesia With Aripiprazole

June 9, 2016

Covert dyskinesia is a masked form of tardive dyskinesia that emerges only after antipsychotic drugs are withdrawn or reduced in dosage. Here, read the case of a 53-year-old man...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe